Appoints Libby Curtis Webb to Senior Vice President of Product
The platform will be used by healthcare providers to simplify the complex and time-consuming process of prescribing specialty medications.
ZappRx, a digital health company that reduces the administrative burden associated with prescribing specialty medications, announced today that Julia Austin has joined its Board of Directors. Over the past several years, Austin has successfully led large organizations in technical positions, and partnered with entrepreneurs to help start and scale technology companies. As a member of its Board, Austin will provide leadership coaching to ZappRx with a focus on engineering, process, staffing, and functional operations.
ZappRx, a digital health company that reduces the administrative burden associated with prescribing specialty medications, today announced that its platform has been deployed at the Division of Pulmonary, Critical Care and Sleep Medicine at Tufts Medical Center, with plans to extend to other areas within the Tufts Medical Center.
Digital health company ZappRx will use the funding to build its team, drive provider adoption nationwide, and accelerate company growth
ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing patient access to specialty therapy, announced a partnership with PARx Solutions (parxsolutions.com), a leader in helping prescribers manage prescription prior authorizations (PA). This strategic partnership combines ZappRx’s expertise in automating the specialty drug prescribing process with PARx’s expertise in helping prescribers overcome challenges experienced during prior authorization that lead to delays in patients receiving their medications.
The process of filling a prescription for a specialty drug can be incredibly time consuming and complex, requiring reams of paperwork from healthcare providers. Zoe Barry, a 31-year-old Wall Street veteran, became interested in tackling those inefficiencies after her younger brother was diagnosed with severe epilepsy.
Boston, MA, September 20, 2016 – ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing patient access to therapy, today announced the hiring of Sandy DiCesare as Chief Operating Officer. DiCesare most recently served as VP of Commercial Operations at Takeda Oncology. She joined Millennium Pharmaceuticals in 1998 as VP, Information Technology and then served as VP, Launch Platform in 2002, leading the build-out of capabilities to support Millennium's first oncology launch. Millennium Pharmaceutical was acquired by Takeda Pharmaceutical Company Limited in 2008.
Boston, MA, April 27, 2016 – ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing efficient patient access to therapy, today announced the hiring of Lorrie Carr as Chief Commercial Officer. Carr previously served as Divisional VP, Enterprise Specialty Sales & Product Management at Walgreens and has held leadership roles in Global Market Access, Sales and Marketing within pharmaceutical companies Millennium Pharmaceuticals (now Takeda Oncology) and Schering-Plough (now Merck).
Boston, MA, December 14, 2015 – Books are gifts that keep on giving. They inspire lifelong learning, and help improve literacy and language skills. That’s why on Tuesday, December 8, 2015, ZappRx employees partnered with Wonderland BookSavers of Connecticut and Reach Out and Read to donate nearly 2,000 books to Floating Hospital for Children at Tufts Medical Center.
Cambridge, MA, September 9, 2015 – Zoë Barry, Founder and CEO of ZappRx, the leading mobile platform that automates specialty drug prescription management for patients, physicians and pharmacists, has been named to Boston Business Journal’s prestigious 40 under 40 list. This year’s list focuses on business and civic leaders who are making a major impact in the community while also improving the civic health of the Boston area through volunteer work and other forms of philanthropy.
Boston, MA, April 2, 2015 – ZappRx (zapprx.com), today announced that it has raised a $5.6M Series A round led by SR One, the venture arm of GlaxoSmithKline, with participation from Atlas Ventures. ZappRx is building the leading mobile platform to automate specialty drug prescription management for patients, physicians, and pharmacists. The company also announced a partnership with biopharmaceutical company Zafgen (NASDAQ: ZFGN), to help automate the prescription management process for patients affected by Prader-Willi syndrome (PWS) and hypothalamic injury-associated obesity (HIAO). Additionally, Jeremy Levin, former CEO of Teva Pharmaceutical, has also joined the board of ZappRx.
ZappRx, a digital health company that reduces the administrative burden associated with prescribing specialty medications, today announced that its platform has been deployed at the Division of Pulmonary, Critical Care and Sleep Medicine at Tufts Medical Center
ZappRx and Digital Pharmacist are completely different businesses but they both use digital technology to help their customers navigate the complex process of drug ordering and related services.
ZappRx, a digital health startup that provides a platform to expedite the process of prescribing specialty drugs, announced today that its solution has been deployed at Tufts Medical Center.
Digital specialty prescribing platform ZappRx has raised $25 million in Series B funding in a round led by Qiming US Healthcare Fund. GV, formerly Google Ventures, and SR One also contributed funding.